Enable job alerts via email!
Boost your interview chances
Create a job specific, tailored resume for higher success rate.
An innovative firm is seeking a Director of Computational Biology and Machine Learning to lead a talented team focused on developing groundbreaking algorithms for cancer detection. This pivotal role requires a unique blend of technical expertise and leadership skills to drive advancements in blood-based testing technologies. You will collaborate with diverse teams to ensure the successful transition of research models into practical applications, ultimately contributing to life-saving solutions for patients. Join a mission-driven organization that values diversity and fosters a culture of collaboration and excellence.
Join to apply for the Director, Computational Biology / Machine Learning role at DELFI Diagnostics
2 weeks ago Be among the first 25 applicants
Join to apply for the Director, Computational Biology / Machine Learning role at DELFI Diagnostics
Get AI-powered advice on this job and more exclusive features.
This range is provided by DELFI Diagnostics. Your actual pay will be based on your skills and experience — talk with your recruiter to learn more.
$191,800.00/yr - $316,440.00/yr
About Us
DELFI Diagnostics, Inc. (DELFI Diagnostics) is developing next-generation, blood-based tests that are reliable, accessible and deliver a new way to help detect cancer. Employing advanced machine-learning methods to whole-genome sequencing data, the DELFI ("DNA EvaLuation of Fragments for early Interception") platform is built to address the highest-burden health challenges. DELFI Diagnostics prioritizes solutions that have the potential to save lives on a global scale, including for historically underserved populations. DELFI Diagnostics’ platform relies on fragmentomics – the discovery that cancer cells are more chaotic than normal cells and, when they die, leave behind tell-tale patterns and characteristics of cell-free DNA (cfDNA) fragments. FirstLook Lung, for individuals eligible for lung cancer screening, is DELFI Diagnostics’ first laboratory-developed screening test and can be part of routine blood work. FirstLook Lung uses millions of data points to reliably identify individuals who may have cancer detected through low-dose CT, including early stage disease with a negative predictive value of 99.8 percent. This test has not been cleared or approved by the FDA.
In our passionate pursuit to radically improve health outcomes, we serve humanity when we:
Lead with Science, Anchor in Pragmatism: We pioneer life-changing science by ensuring quality, transparency, and rigor at all times. We explore thoughtfully, experiment smartly, and deliver impact with conviction.
Build With & For All: We embrace diverse backgrounds to innovate and achieve together. We are not just building a product - we aim to disrupt the path of cancer for all - no matter geography or socioeconomic class
Put We over I: We are a home for high-performing people. Through teamwork, we build collective intelligence. Each of us wins when those we serve and those who serve with us--win. We show up with empathy, humility, and integrity at every step of the journey.
DELFI has 1-2 designated in-office working days each week for employees who live within within 50 miles of Palo Alto CA or Baltimore MD offices
This role is responsible for leading a technical team focused on developing and validating computational algorithms for cancer detection using blood-based omics data. You will lead cross-functional collaboration with assay development teams, clinical data scientists, and software engineers to successfully transition cutting-edge research models into production environments. This position requires a unique blend of technical leadership, scientific expertise, and collaborative skills to advance cancer detection technologies from research concepts to practical applications.
About Us
DELFI Diagnostics, Inc. (DELFI Diagnostics) is developing next-generation, blood-based tests that are reliable, accessible and deliver a new way to help detect cancer. Employing advanced machine-learning methods to whole-genome sequencing data, the DELFI ("DNA EvaLuation of Fragments for early Interception") platform is built to address the highest-burden health challenges. DELFI Diagnostics prioritizes solutions that have the potential to save lives on a global scale, including for historically underserved populations. DELFI Diagnostics’ platform relies on fragmentomics – the discovery that cancer cells are more chaotic than normal cells and, when they die, leave behind tell-tale patterns and characteristics of cell-free DNA (cfDNA) fragments. FirstLook Lung, for individuals eligible for lung cancer screening, is DELFI Diagnostics’ first laboratory-developed screening test and can be part of routine blood work. FirstLook Lung uses millions of data points to reliably identify individuals who may have cancer detected through low-dose CT, including early stage disease with a negative predictive value of 99.8 percent. This test has not been cleared or approved by the FDA.
In our passionate pursuit to radically improve health outcomes, we serve humanity when we:
Lead with Science, Anchor in Pragmatism: We pioneer life-changing science by ensuring quality, transparency, and rigor at all times. We explore thoughtfully, experiment smartly, and deliver impact with conviction.
Build With & For All: We embrace diverse backgrounds to innovate and achieve together. We are not just building a product - we aim to disrupt the path of cancer for all - no matter geography or socioeconomic class
Put We over I: We are a home for high-performing people. Through teamwork, we build collective intelligence. Each of us wins when those we serve and those who serve with us--win. We show up with empathy, humility, and integrity at every step of the journey.
DELFI has 1-2 designated in-office working days each week for employees who live within within 50 miles of Palo Alto CA or Baltimore MD offices
This role is responsible for leading a technical team focused on developing and validating computational algorithms for cancer detection using blood-based omics data. You will lead cross-functional collaboration with assay development teams, clinical data scientists, and software engineers to successfully transition cutting-edge research models into production environments. This position requires a unique blend of technical leadership, scientific expertise, and collaborative skills to advance cancer detection technologies from research concepts to practical applications.
What you’ll doWe are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
This position is not eligible for agency partnership. Resumes and outreach from staffing representatives will be declined.
Referrals increase your chances of interviewing at DELFI Diagnostics by 2x
Get notified about new Director Biology jobs in Palo Alto, CA.
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.